Predictors of Opioid Prescription After Early Stage Lung Cancer Surgery (Reply)

Publication date: Available online 29 January 2019Source: The Annals of Thoracic SurgeryAuthor(s): Alexander A. Brescia, Caitlin A. Harrington, Jennifer F. Waljee, Kiran H. Lagisetty
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research

Related Links:

PMID: 31194491 [PubMed - in process]
Source: American Family Physician - Category: Primary Care Authors: Tags: Am Fam Physician Source Type: research
Opinion statementIsolation and analysis of circulating tumor DNA (ctDNA) have emerged as an effective and promising tool for genomic profiling in non-small cell lung cancer. Analysis of ctDNA can be particularly useful in situations where tissue biopsy is not safely obtainable due to poor physical condition or inaccessible tumor biopsy location. In addition to identifying oncogenic driver mutations which can be treated with targetable therapy in the treatment na ïve advanced non-small cell lung cancer (NSCLC) setting, ctDNA is being utilized in novel ways including monitoring during an advanced NSCLC patient’s t...
Source: Current Treatment Options in Oncology - Category: Cancer & Oncology Source Type: research
Condition:   NSCLC Interventions:   Drug: Kanglaite Injection+Chemotherapy;   Drug: Chemotherapy Sponsors:   Jie Li;   Ministry of Science and Technology of the People´s Republic of China;   Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Lung Neoplasms;   Lung Cancer;   Neoplasm of Lung;   Non Small Cell Lung Cancer Intervention:   Other: Circulating tumour DNA (ctDNA) Sponsor:   Lawson Health Research Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
I just cannot understand why it is so difficult to get people to grasp what seems to me a simple idea. Let's try one more time.The purpose of insurance is to spread risk. That's the essence of the concept. Health insurance (or health care insurance as some prefer to say) is different from other kinds of insurance in some ways, so let's just talk about health insurance.Health care costs are unpredictable. It is true that there are risk factors associated with some conditions, most notably smoking tobacco. Nevertheless, no matter how healthful your lifestyle, you still just might need expensive health care. You might be hit ...
Source: Stayin' Alive - Category: American Health Source Type: blogs
FRIDAY, June 14, 2019 -- Cardiac radiation dose exposure is a modifiable cardiac risk factor for major adverse cardiac events (MACE) and all-cause mortality (ACM) in patients with non-small cell lung cancer (NSCLC), according to a study published in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
The trust at the centre of a lung cancer deaths scandal has been identified as an outlier for providing surgery on fewer early stage patients than is normal.
Source: HSJ - Category: UK Health Source Type: news
In conclusion, our results suggest that LIG may be a useful therapy for human lung carcinoma.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
CT lung cancer screening reduced cancer mortality by 69% in high-risk female...Read more on AuntMinnie.comRelated Reading: Risk models boost efficiency of CT lung cancer screening Prolonged CT lung screening offers cumulative benefits CT lung screening spots cancers earlier in China CT lung screening cuts cancer mortality 51% in Japan CT lung screening reduces cancer mortality in men by 26%
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Authors: Carausu M, Bidard FC, Callens C, Melaabi S, Jeannot E, Pierga JY, Cabel L Abstract Introduction: In hormone receptor-positive breast cancer, ESR1 mutations have emerged as a key mechanism of resistance to endocrine therapy. Areas covered: Here, we review currently available data on ESR1 mutations, regarding their functional impact, prevalence at different stages (and according to the material used: tissue-based analysis vs liquid biopsy), prognostic impact and predictive value of resistance to aromatase inhibitors. Possible strategies to overcome this resistance by using selective estrogen receptor downreg...
Source: Expert Review of Molecular Diagnostics - Category: Laboratory Medicine Tags: Expert Rev Mol Diagn Source Type: research
More News: Cancer | Cancer & Oncology | Cardiovascular & Thoracic Surgery | Lung Cancer